The Gemcitabine Hydrochloride market was valued at US$ 873.1 million in 2025 and is expected to reach US$ 1,297.83 million by 2034. The market is estimated to record a CAGR of 4.5% during 2026–2034. The increasing prevalence of cancer, rising demand for effective chemotherapy medications, growing awareness of early cancer diagnosis, and expanding access to oncology treatments are among...
The global Doxorubicin Market is witnessing steady growth, supported by the increasing prevalence of cancer and the growing preference for chemotherapy treatments worldwide. The market size is projected to reach US$ 2.35 billion by 2031 from US$ 1.47 billion in 2023. The market is expected to register a compound annual growth rate (CAGR) of 6.1% during 2023–2031. Increasing demand for...
The High Potency API Contract Manufacturing Market is expected to expand from US$9.1 billion in 2025 to US$20.51 billion by 2034, registering a CAGR of 10.69% from 2026 to 2034. Market growth is being driven by the increasing development of targeted therapies, oncology drugs, and other pharmaceutical products requiring highly potent active pharmaceutical ingredients. Rising...
According to the latest report published by Data Bridge Market Research, the Blood Cancer Market
Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032.
A team involved in preparing this Blood Cancer Market research report has kept certain things into...
